Evidence map›Paper›PMID 37635183›Full record

ArticleBlood cancer journal2023

Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.

Arleigh McCurdy, Hira Mian, Richard LeBlanc, Victor H Jimenez-Zepeda, Jiandong Su, Esther Masih-Khan, Alissa Visram, Martha Louzada, Kevin Song, Darrell White and 10 more

Abstract readPublished Erratum
In one paragraph

Article in Blood cancer journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Arleigh McCurdyOttawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada. amccurdy@toh.ca.ORCID http://orcid.org/0000-0002-8809-4368
Hira MianJuravinski Cancer Center, Hamilton, ON, Canada.ORCID http://orcid.org/0000-0003-1584-1067
Richard LeBlancMaisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, QC, Canada.
Victor H Jimenez-ZepedaArnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.
Jiandong SuCanadian Myeloma Research Group, Vaughn, ON, Canada.
Esther Masih-KhanCanadian Myeloma Research Group, Vaughn, ON, Canada.
Alissa VisramOttawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0002-7201-4642
Martha LouzadaDepartment of Medicine, London Regional Cancer Center, London, ON, Canada.
Kevin SongBC Cancer Agency, Vancouver General Hospital, Vancouver, BC, Canada.
Darrell WhiteQueen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada.
Michael SebagDepartment of Medicine, McGill University, Montreal, QC, Canada.
Julie StakiwSaskatoon Cancer Centre, University of Saskatchewan, Saskatoon, SK, Canada.
Anthony ReimanDepartment of Medicine, Saint John Regional Hospital, Saint John, NB, Canada.
Muhammad AslamDepartment of Medical Oncology, Allan Blair Cancer Centre, Regina, SK, Canada.
Debra BergstromDivision of Hematology, Memorial University of Newfoundland, St John's, NL, Canada.
Rami KotbDepartment of Medical Oncology & Hematology, Cancer Care Manitoba, Winnipeg, MB, Canada.
Rayan KaedbeyDepartment of Medicine, Jewish General Hospital, Montreal, QC, Canada.
Engin GulCanadian Myeloma Research Group, Vaughn, ON, Canada.
Donna ReeceCanadian Myeloma Research Group, Vaughn, ON, Canada.
Christopher P VennerBC Cancer Agency, Vancouver General Hospital, Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37635183
PMCPMC10460788

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.